Evidence map›Paper›PMID 29321314›Full record

ArticleJournal of virology2018

HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.

Zachary Ende, Martin J Deymier, Daniel T Claiborne, Jessica L Prince, Daniela C Mónaco, William Kilembe, Susan A Allen, Eric Hunter

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zachary EndeEmory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Martin J DeymierEmory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Daniel T ClaiborneEmory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Jessica L PrinceEmory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Daniela C MónacoEmory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
William KilembeZambia-Emory HIV Research Project, Lusaka, Zambia.
Susan A AllenZambia-Emory HIV Research Project, Lusaka, Zambia.
Eric HunterEmory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA ehunte4@emory.edu.
Emory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
CTL and HIV Polymorphisms in Heterosexual TransmissionR01AI064060 · NIAID · EMORY UNIVERSITY · PI GOEPFERT, PAUL A., HUNTER, ERIC · 2005 to 2019
$21.7M
Virologic Correlates of Heterosexual TransmissionR37AI051231 · NIAID · EMORY UNIVERSITY · PI HUNTER, ERIC · 2008 to 2017
$9.6M
NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI064060NIAID NIH HHS R37 AI051231NIH HHS P51 OD011132
6 · The paper itself

Abstract

HIV-1 downregulates human leukocyte antigen A (HLA-A) and HLA-B from the surface of infected cells primarily to evade CD8 T cell recognition. HLA-C was thought to remain on the cell surface and bind inhibitory killer immunoglobulin-like receptors, preventing natural killer (NK) cell-mediated suppression. However, a recent study found HIV-1 primary viruses have the capacity to downregulate HLA-C. The goal of this study was to assess the heterogeneity of HLA-A, HLA-B, and HLA-C downregulation among full-length primary viruses from six chronically infected and six newly infected individuals from transmission pairs and to determine whether transmitted/founder variants exhibit common HLA class I downregulation characteristics. We measured HLA-A, HLA-B, HLA-C, and total HLA class I downregulation by flow cytometry of primary CD4 T cells infected with 40 infectious molecular clones. Primary viruses mediated a range of HLA class I downregulation capacities (1.3- to 6.1-fold) which could differ significantly between transmission pairs. Downregulation of HLA-C surface expression on infected cells correlated with susceptibility to

Indexed as

HIV-1HIV InfectionsHIV SeropositivityHLA-A AntigensHLA-B AntigensHLA-C AntigensHost-Pathogen InteractionsHuman Immunodeficiency Virus ProteinsHumansImmune EvasionKiller Cells, Naturalnef Gene Products, Human Immunodeficiency VirusT-LymphocytesViral Regulatory and Accessory ProteinsViroporin ProteinsHLA-A AntigensHLA-B AntigensHLA-C AntigensHuman Immunodeficiency Virus Proteinsnef Gene Products, Human Immunodeficiency VirusViral Regulatory and Accessory ProteinsViroporin Proteinsvpu protein, Human immunodeficiency virus 1HIV-1HLAhuman immunodeficiency virushuman leukocyte antigen class Inatural killer cellsNefNK cellsquasispeciestransmitted/founder virusVpu

Identifiers

PMID29321314
PMCPMC5972908
OpenAlexW2783514037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.